Tvardi Therapeutics Azioni (NASDAQ: TVRD)

Tvardi Therapeutics (NASDAQ:TVRD) Azioni, Quote.MetaTitle.unusual-options

Tvardi Therapeutics

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Vendite allo scoperto

Rapporto azionario

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Comments

Tvardi Therapeutics Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO